Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-068008
Filing Date
2024-03-14
Accepted
2024-03-14 17:07:06
Documents
5
Effectiveness Date
2024-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 d741518ds8.htm S-8 53056
2 EX-5.1 d741518dex51.htm EX-5.1 7361
3 EX-23.1 d741518dex231.htm EX-23.1 1472
4 EX-FILING FEES d741518dexfilingfees.htm EX-FILING FEES 13618
5 GRAPHIC g741518g0312202416803.jpg GRAPHIC 2652
  Complete submission text file 0001193125-24-068008.txt   80544
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277945 | Film No.: 24751193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)